Sandostatin LAR Stungulyfsstofn og leysir, dreifa 30 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 30 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 30 mg

Sandostatin LAR Stungulyfsstofn og leysir, dreifa 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 10 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 10 mg

Sandostatin LAR Stungulyfsstofn og leysir, dreifa 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin lar stungulyfsstofn og leysir, dreifa 20 mg

novartis healthcare a/s - octreotidum inn - stungulyfsstofn og leysir, dreifa - 20 mg

Sandostatin Stungulyf, lausn 100 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin stungulyf, lausn 100 míkróg/ml

novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 100 míkróg/ml

Sandostatin Stungulyf, lausn 50 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

sandostatin stungulyf, lausn 50 míkróg/ml

novartis healthcare a/s - octreotidum inn - stungulyf, lausn - 50 míkróg/ml